Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.
about
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivoBinding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein.
P2860
Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Use of a human immunodeficienc ...... te for potential AIDS therapy.
@en
Use of a human immunodeficienc ...... te for potential AIDS therapy.
@nl
type
label
Use of a human immunodeficienc ...... te for potential AIDS therapy.
@en
Use of a human immunodeficienc ...... te for potential AIDS therapy.
@nl
prefLabel
Use of a human immunodeficienc ...... te for potential AIDS therapy.
@en
Use of a human immunodeficienc ...... te for potential AIDS therapy.
@nl
P2093
P2860
P1433
P1476
Use of a human immunodeficienc ...... ate for potential AIDS therapy
@en
P2093
P2860
P304
P407
P577
1995-03-01T00:00:00Z